Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Dr. Bekker discusses results from key studies reported at the 4th HIV Research for Prevention Conference (HIVR4P // Virtual), including results from studies evaluating novel approaches to HIV prevention such as broadly neutralizing antibodies, long-acting injectable and oral ARVs, and implantable options. In addition, Dr. Bekker will discuss several studies evaluating different aspects of PrEP implementation and acceptance as well as considerations for multipurpose prevention strategies.
Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD
Desmond Tutu HIV Centre
International AIDS Society
Faculty of Health Sciences
University of Cape Town
Cape Town, South Africa
Latesha Elopre and CCO: starting HIV pre-exposure prophylaxis (PrEP). DISCOVER study, CDC guidance, racial/ethnic disparities, overcoming barriers
Slides from Latesha Elopre and CCO: starting HIV preexposure prophylaxis (PrEP). DISCOVER study, CDC guidance, racial/ethnic disparities, overcoming barriers.
Clinical Care Options (CCO) podcast with Dr. David Hardy discussing current PrEP options and exciting data on drugs for next-generation HIV prevention
In this vlog from Clinical Care Options (CCO), Dr. Ethel Weld demonstrates HIV-ASSIST as a resource for selecting ART in a patient with comorbidities